Tumor angiogenesis in mice and men

Rhoda M Alani1, Courtney F Silverthorn, Kate Orosz

  • 1The Sidney Kimmel Comprehensive Cancer Center, Program in Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231-1000, USA. ralani@jhmi.edu

Insights

Id genes play a crucial role in tumor angiogenesis. Recent studies using clinically relevant models show different results than earlier xenograft data, prompting a re-evaluation of their function in tumor vasculature development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Developmental Biology

Background:

  • Extensive research has explored molecular pathways regulating tumor-associated vasculature development.
  • Previous studies in 1999 indicated Id1/Id3 gene deficiency impairs tumor xenograft growth via defective angiogenesis.

Purpose of the Study:

  • To review the current understanding of Id gene roles in tumor vasculature development.
  • To reconcile conflicting data from recent studies with earlier findings.
  • To suggest improvements for clinically relevant animal tumor model systems.

Main Methods:

  • Review of three recent publications examining Id gene function in tumor vasculature.
  • Comparison of findings with original 1999 xenograft data.
  • Analysis of data from clinically relevant tumor model systems.

Main Results:

  • Three recent studies report significantly different findings compared to the 1999 xenograft data.
  • The role of Id genes in tumor-associated angiogenesis appears more complex than initially suggested.
  • New data challenges the original conclusions regarding Id gene necessity for tumor vascularization.

Conclusions:

  • The function of Id genes in tumor vasculature development requires re-evaluation based on recent findings.
  • Clinically relevant tumor models provide critical insights that differ from traditional xenografts.
  • Optimizing animal tumor models is essential for generating more translatable research findings.